4//SEC Filing
Hollander David 4
Accession 0001209191-19-056323
CIK 0001337553other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:08 PM ET
Size
7.7 KB
Accession
0001209191-19-056323
Insider Transaction Report
Form 4
Hollander David
Chief R&D Officer
Transactions
- Award
Common Stock
2019-11-11+25,000→ 25,000 total - Award
Stock Option (right to buy)
2019-11-11+110,000→ 110,000 totalExercise: $19.05Exp: 2029-11-11→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of November 11, 2019.
- [F2]This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on November 11, 2020 and as to the remaining underlying shares in substantially equal installments on each of the first 36 monthly anniversaries of November 11, 2020.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001793796
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:08 PM ET
- Size
- 7.7 KB